10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025
Introduction
The 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025 is a comprehensive continuing medical education program developed by Continuing Education Company to provide primary care clinicians with practical, evidence-informed updates in cardiometabolic medicine. Recorded from the live conference held April 25–27, 2025 at The Westin San Diego Gaslamp Quarter, this educational program focuses on the rapidly evolving management of diabetes, obesity, cardiovascular risk, renal disease, hypertension, dyslipidemia, and metabolic dysfunction-associated liver disease.
Designed for clinicians managing increasingly complex cardiometabolic conditions in outpatient practice, the course emphasizes clinically actionable strategies that can be implemented immediately in patient care. The curriculum explores modern obesity pharmacotherapy, the cardiovascular-kidney-metabolic syndrome, updated diabetes standards of care, HFpEF recognition, lipid disorders, metabolic liver disease, and integrated risk reduction approaches for patients with obesity and type 2 diabetes.
With expert-led HD video lectures, downloadable presentation slides, and self-paced online access, the program delivers practical guidance for improving cardiometabolic outcomes while strengthening preventive care and chronic disease management in modern primary care practice.
Files Included
The 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025 educational package includes multimedia cardiometabolic medicine learning resources designed for flexible professional education.
Included resources:
- 16 HD-quality video lectures
- Downloadable presentation slides and handouts
- Approximately 20 hours of educational content
- Cardiometabolic disease management updates
- Obesity medicine educational sessions
- Diabetes and lipid management reviews
- Case-based clinical discussions
- CME365™ online streaming access
Additional highlights:
- Release date: April 2025
- 15.25 CME/CE credits available
- ABIM MOC eligibility
- Self-paced online learning access
These resources support continuing education in diabetes care, obesity medicine, preventive cardiology, metabolic disease management, and primary care medicine.
Why This Course Is Important
Cardiometabolic disease has become one of the most significant global healthcare challenges, with obesity, type 2 diabetes, hypertension, dyslipidemia, chronic kidney disease, fatty liver disease, and cardiovascular disease increasingly occurring together in complex high-risk patient populations. More than one-third of adults are affected by cardiometabolic disorders, contributing substantially to long-term morbidity, mortality, and healthcare utilization.
At the same time, the therapeutic landscape continues to evolve rapidly with newer anti-obesity medications, updated diabetes standards, expanding cardiovascular-kidney-metabolic treatment strategies, and growing understanding of metabolic dysfunction-associated liver disease and HFpEF.
Primary care clinicians must remain current with changing guidelines, pharmacologic advances, and integrated treatment approaches to effectively manage these interconnected chronic diseases.
The 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025 addresses these needs through a practical, multidisciplinary curriculum focused on real-world cardiometabolic management and evidence-informed patient care strategies.
What Participants Will Learn
Participants completing this course will strengthen their expertise in diabetes management, obesity treatment, cardiovascular risk reduction, and metabolic disease care.
Learning objectives include:
- Applying the 2025 ADA Standards of Care in clinical practice
- Understanding obesity as a driver of cardiometabolic disease
- Integrating cardiovascular-kidney-metabolic treatment strategies
- Recognizing and managing HFpEF in high-risk patients
- Optimizing obesity treatment outcomes using lifestyle and pharmacologic approaches
- Understanding the biology and pathophysiology of obesity
- Applying anti-obesity medications safely and effectively
- Diagnosing and managing MASLD and MASH
- Evaluating secondary causes of hypertension
- Managing dyslipidemia including LDL-C, ApoB, triglycerides, and lipoprotein(a) abnormalities
The curriculum integrates obesity medicine, endocrinology, preventive cardiology, nephrology, hepatology, hypertension management, and metabolic disease education into a clinically practical learning experience.
Full Course Topics & Lectures
Diabetes & Cardiometabolic Medicine
2025 ADA Standards of Care
Cases in Diabetes
Treating Obesity to Treat Diabetes
Cardiovascular-Kidney-Metabolic Syndrome
Renal and Cardio-Kidney Metabolic Disease
Obesity Medicine & Weight Management
The Biology of Obesity
Harnessing Anti-Obesity Medications
Strategies for Optimizing Outcomes of Obesity Treatment
Cases in Obesity Management
Midlife Metamorphosis in Women
Cardiovascular & Heart Failure Topics
Identifying and Treating HFpEF
Secondary Causes of Hypertension
Cases in Hypertension and Dyslipidemia
Cardiovascular Risk Reduction Strategies
Lipidology & Dyslipidemia
Treatment of LDL-C, Non-HDL-C and Apo B
Triglycerides and Lipoprotein(a)
Lipid Management in Cardiometabolic Disease
Preventive Cardiology Approaches
Liver & Metabolic Disease
Diagnosis and Management of MASLD/MASH
Metabolic Dysfunction and Liver Disease
Obesity-Related Hepatic Disorders
Educational Experience & Learning Features
The 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025 combines practical cardiometabolic education with flexible self-paced learning and evidence-informed treatment updates.
Educational features include:
- 16 HD-quality expert-led video lectures
- Downloadable presentation slides and handouts
- Approximately 20 hours of educational content
- Self-paced online streaming access via CME365™
- Case-based cardiometabolic learning
- Guideline-focused clinical updates
- Obesity medicine and diabetes management reviews
- Preventive cardiology education
- Practical outpatient management strategies
- CME and ABIM MOC credit opportunities
The curriculum integrates diabetes care, obesity medicine, lipidology, nephrology, preventive cardiology, and metabolic disease management into a clinically practical educational platform.
Who Should Take This Course
The 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025 is intended for clinicians involved in outpatient chronic disease management and cardiometabolic care.
This course is especially valuable for:
- Primary care physicians
- Family medicine physicians
- Internal medicine physicians
- Endocrinologists
- Cardiologists
- Obesity medicine clinicians
- Nurse practitioners
- Physician assistants
- Nurses involved in chronic disease management
- Healthcare professionals managing cardiometabolic disorders
The curriculum is particularly relevant for clinicians seeking updated expertise in diabetes care, obesity treatment, lipid management, hypertension, metabolic liver disease, and preventive cardiovascular medicine.
Clinical Applications & Practice Benefits
The course provides clinically practical education focused on improving cardiometabolic disease management and preventive care strategies.
Participants gain practical insight into:
- Modern obesity pharmacotherapy integration
- Type 2 diabetes treatment optimization
- HFpEF recognition and management
- Cardiovascular-kidney-metabolic syndrome treatment approaches
- Lipid and lipoprotein risk reduction strategies
- Hypertension evaluation and secondary cause assessment
- MASLD/MASH diagnosis and management
- Lifestyle and preventive medicine interventions
- Long-term cardiometabolic risk reduction
- Evidence-informed outpatient treatment planning
The educational content strengthens clinical confidence while supporting improved outcomes in patients with obesity, diabetes, and metabolic disease.
Professional Summary
The 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025 from Continuing Education Company provides a comprehensive and clinically practical review of modern cardiometabolic medicine, obesity treatment, diabetes management, and preventive cardiovascular care.
Recorded from the live conference at The Westin San Diego Gaslamp Quarter, the curriculum explores updated ADA standards, anti-obesity medications, HFpEF, lipid disorders, hypertension, cardio-kidney-metabolic disease, and metabolic liver disease through expert-led lectures and case-based clinical discussions.
Its integration of practical outpatient strategies, evidence-informed medicine, flexible self-paced learning, and multidisciplinary cardiometabolic education makes this program a valuable educational resource for clinicians managing obesity, diabetes, cardiovascular risk, and chronic metabolic disease.
Course Content
| On Demand Replay: FRIDAY, April 25, 2025 DAY 1 – Diabetes and Cardio-Renal Disease Management with Cases |
|
| M. McDonnell, MD | Treating Obesity to Treat Diabetes: Cutting the Gordian Knot |
| N. Desai, MD | The Cardiovascular-Kidney-Metabolic Syndrome: Timely Identification, Optimal Management, and Lingering Questions |
| M. McDonnell, MD | Highlights from the 2025 ADA Standards of Care: Drug Selection, Technology and Nutrition |
| N. Desai, MD | Identifying and Treating HFpEF: It’s All About the Phenotype… |
| M. McDonnell, MD & N. Desai, MD | Cases in Diabetes, Renal and Cardio-Kidney Metabolic Disease |
| On Demand Replay: SATURDAY, April 26, 2025 DAY 2 – Comprehensive Obesity Management and MASLD/MASH with Case Studies |
|
| L. Kaplan, MD | The Biology of Obesity and its Implications for Effective Treatment |
| D. Thiara, MD | Beyond the Scale: Harnessing Anti-Obesity Medications to Treat Obesity and its Complications |
| D. Thiara, MD | Midlife Metamorphosis in Women: Tackling Obesity During Aging and Menopause |
| L. Kaplan, MD | Strategies for Optimizing Outcomes of Obesity Treatment |
| L. Kaplan, MD & D. Thiara, MD | Cases in Obesity Management |
| M. Rinella, MD | Diagnosis and Management of MASLD/MASH |
| M. Rinella, MD | Cases in the Diagnosis and Management of MASLD/MASH |
| On Demand Replay: SUNDAY, April 27, 2025 DAY 3 – Hypertension and Dyslipidemia Management with Case Studies |
|
| J. Basile, MD (Chairperson) | Update on Secondary Causes of Hypertension |
| C. Ballantyne, MD | Treatment of LDL-C, Non-HDL-C and Apo B-Statins and Beyond |
| C. Ballantyne, MD | Triglycerides and Lp(a): Where Are We Now and Where Are We Going? |
| J. Basile, MD & C. Ballantyne, MD | Cases in Hypertension and Dyslipidemia |
Course Objectives
As a result of this educational activity, participants should be better able to:
- Diagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.
- Integrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.
- Incorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.
Target Audience
This activity is designed for physicians, nurse practitioners, physician assistants, and other healthcare professionals specializing in primary care and family medicine.









